{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:53:01Z","timestamp":1781927581293,"version":"3.54.5"},"reference-count":12,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.26-0286","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:11:49Z","timestamp":1781734309000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Emergency Appendectomy during the Early Phase after &lt;sup&gt;177&lt;\/sup&gt;Lu-DOTATATE Therapy: A Case Report with Perioperative Radiation Safety after PRRT"],"prefix":"10.70352","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-5674","authenticated-orcid":false,"given":"Kei","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Fukata","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Yambe","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kondo","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1284-4619","authenticated-orcid":false,"given":"Kazuhiro","family":"Takami","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniharu","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-8003","authenticated-orcid":false,"given":"Yu","family":"Katayose","sequence":"additional","affiliation":[{"name":"Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Panzuto F, Lamarca A, Fazio N. Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumors. Cancer Treat Rev 2024; 129: 102803.","DOI":"10.1016\/j.ctrv.2024.102803"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Bidani K, Marinovic AG, Moond V, et al. Treatment of pancreatic neuroendocrine tumors: beyond traditional surgery and targeted therapy. J Clin Med 2025; 14: 3389.","DOI":"10.3390\/jcm14103389"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Singh S, Halperin D, Myrehaug S, et al. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): An open-label, randomised, phase 3 study. Lancet 2024; 403: 2807\u201317.","DOI":"10.1016\/S0140-6736(24)00701-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Podda M, Sartelli M, Kari A, et al. Diagnosis and treatment of acute appendicitis: 2025 edition of the World Society of Emergency Surgery Jerusalem guidelines. JAMA Surg 2026; 161: 123\u201345.","DOI":"10.1001\/jamasurg.2025.6218"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Milan SA, Yeo CJ. Neuroendocrine tumors of the pancreas. Curr Opin Oncol 2012; 24: 46\u201355.","DOI":"10.1097\/CCO.0b013e32834c554d"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Valle JW, Eatock M, Clueit B, et al. A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours. Cancer Treat Rev 2014; 40: 376\u201389.","DOI":"10.1016\/j.ctrv.2013.08.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Rikhraj N, Fernandez CJ, Ganakumar V, et al. Pancreatic neuroendocrine tumors: A case-based evidence review. World J Gastrointest Pathophysiol 2025; 16: 107265.","DOI":"10.4291\/wjgp.v16.i2.107265"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Fischer L, Bergmann F, Schimmack S, et al. Outcome of surgery for pancreatic neuroendocrine neoplasms. Br J Surg 2014; 101: 1405\u201312.","DOI":"10.1002\/bjs.9603"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hofving T, Sandblom V, Arvidsson Y, et al. <sup>177<\/sup>Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition. Endocr Relat Cancer 2019; 26: 437\u201349.","DOI":"10.1530\/ERC-18-0509"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Bodei L, \u0106wikla JB, Kidd M, et al. The role of peptide receptor radionuclide therapy in advanced\/metastatic thoracic neuroendocrine tumors. J Thorac Dis 2017; 9(Suppl 15): S1511\u201323.","DOI":"10.21037\/jtd.2017.09.82"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med 2017; 376: 125\u201335.","DOI":"10.1056\/NEJMoa1607427"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bodei L, Gnanasegaran G, Giammarile F, et al. Joint EANM, IAEA, and SNMMI practical guidance on somatostatin receptor-targeted radionuclide therapy of neuroendocrine tumours. The EANM Journal. 2026: 100017.","DOI":"10.1016\/j.eanmj.2026.100017"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0286\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:40:41Z","timestamp":1781926841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0286\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.26-0286","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.26-0286"}}